Does dentistry need to shake up its approach to gum disease?
Identifying patients at greater risk of having active and progressing periodontal disease remains challenging, so it may be time for a new approach, according to a commentary published on May 4 in the Journal of the American Dental Association. Having access to new tools and resources, including point-of-care testing, that focus on biomarkers of periodontal disease activity could result in earlier and improved decisions regarding treatment, prognosis, and recall scheduling,


